GlassScriptPhysician profile
Qing Tian
NPI 1700814886
$1,414.70
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.38 · 2020: $74.27 · 2021: $247 · 2022: $312 · 2023: $93.77 · 2024: $284 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $636.22 | 2019-2025 | Xpress Loprofile |
| Regeneron Healthcare Solutions, INC. | $203.62 | 2024-2025 | Dupixent |
| Smith+Nephew, INC. | $122.39 | 2022-2025 | Halo, Ent Sinus |
| Neurent Medical Limited | $93.46 | 2022-2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Genzyme Corporation | $84.49 | 2024-2025 | |
| Glaxosmithkline, LLC. | $78.39 | 2025 | Nucala |
| Phadia US INC. | $62.54 | 2023-2025 | Immunocap |
| Optinose US, INC. | $39.10 | 2024 | |
| Intersect Ent, INC. | $27.92 | 2022 | |
| Medtronic, INC. | $27.25 | 2025 | Pteye Parathyroid Detection System |
| Ethicon US, LLC | $24.08 | 2024 | Harmonic |
| Acelrx Pharmaceuticals, INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qing Tian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.